AMCE to establish cyclotron facility for advanced diagnosis, treatment

The African Medical Centre of Excellence (AMCE), a tertiary-level multi-specialty medical institution, says its centre in Abuja will have a cyclotron facility.

This announcement was made on Friday during a site tour of the medical centre, which is scheduled for commissioning in the first quarter of 2025.

A cyclotron is a particle accelerator used to produce radioisotopes for nuclear medicine, essential for imaging and research.

This advanced technology will be key in diagnosing and treating complex diseases such as cancer, cardiovascular ailments, and neurological disorders — all of which AMCE will specialise in.

Brian Deaver, CEO of AMCE, highlighted the significance of the cyclotron facility, describing it as “a monumental leap forward in medical advancement and access across the continent.”

He noted the scarcity of cyclotron technology in West Africa, with only one operational facility currently serving the region.

AMCE’s new cyclotron will help bridge this gap, offering vital access to state-of-the-art medical technology.

“This facility will not only elevate our diagnostic capabilities but also democratise access to cutting-edge treatment options that have historically been out of reach for most people in Africa,” Deaver said.

“Enhancing the accuracy and speed of disease detection and treatment will play a vital role in saving lives and improving patient outcomes.”

By producing radiopharmaceuticals in-house, the facility will ensure the highest quality of care for patients, furthering AMCE’s mission to deliver accessible, world-class healthcare across Africa.

Beyond its immediate impact on diagnostics, the cyclotron will also promote innovation and research aimed at improving treatment for chronic conditions.

“By bringing this technology to West Africa, we are not just enhancing local healthcare infrastructure; we are also laying the groundwork for a self-sufficient and resilient healthcare system,” Deaver added.

He added that the facility will serve as a hub for collaboration among researchers, clinicians and industry experts in a bid to address the region’s healthcare challenges.